|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/0781 | (2010.01) |
| C12N 5/0636 | (2013.01) | ||
| C12N 5/0783 | (2010.01) | ||
| C12N2501/599 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| Y02P 20/582 | (2015.11) | ||
| C12N2510/00 | (2013.01) | ||
| A61K 39/4644 | (2023.05) | ||
| A61K 39/4631 | (2023.05) | ||
| A61K 39/4611 | (2023.05) |
| (11) | Number of the document | 4219687 |
| (13) | Kind of document | T |
| (96) | European patent application number | 23164036.8 |
| Date of filing the European patent application | 2015-04-23 | |
| (97) | Date of publication of the European application | 2023-08-02 |
| (45) | Date of publication and mention of the grant of the patent | 2024-08-14 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201461983415 P | 2014-04-23 | US |
| (72) |
RAMSBORG, Chris , US
BONYHADI, Mark, L , US
CHAN, Calvin , US
BEAUCHESNE, Pascal , US
|
| (73) |
Juno Therapeutics, Inc. ,
400 Dexter Ave. N, Suite 1200, Seattle, WA 98109,
US
|
| (54) | METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY |
| METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY |